Imatinib, cytokines and interstitial lung disease in a patient with primary myelofibrosis.
Robibaro
Bruno
B
Kropfmueller
Anna
A
Prokop
Mathias
M
Haber
Paul
P
Gisslinger
Heinz
H
D001549:Benzamides; D016207:Cytokines / Q000276:immunology*; D006801:Humans; D000068877:Imatinib Mesylate; D017563:Lung Diseases, Interstitial / Q000139:chemically induced* / Q000209:etiology / Q000276:immunology* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000009:adverse effects* / Q000627:therapeutic use; D055728:Primary Myelofibrosis / Q000150:complications / Q000188:drug therapy* / Q000276:immunology* / Q000473:pathology; D011743:Pyrimidines / Q000009:adverse effects* / Q000627:therapeutic use
D001549:Benzamides; D016207:Cytokines; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate